Palvella Therapeutics
Price & Volume
Stats
See more52W Range | $6.20-$22.32 |
Market Cap | $219.3M |
Shares Short | 17,355 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | $1.97 |
About
CEO | Mr. Wesley H. Kaupinen |
CFO | Mr. Matthew E. Korenberg |
Address | 125 Strafford Avenue, Wayne, PA, United States, 19087 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 0 |
